Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BERARDINELLI W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol Metab. 1954 Feb;14(2):193–204. doi: 10.1210/jcem-14-2-193. [DOI] [PubMed] [Google Scholar]
- Burn J., Baraitser M. Partial lipoatrophy with insulin resistant diabetes and hyperlipidaemia (Dunnigan syndrome). J Med Genet. 1986 Apr;23(2):128–130. doi: 10.1136/jmg.23.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dunnigan M. G., Cochrane M. A., Kelly A., Scott J. W. Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Q J Med. 1974 Jan;43(169):33–48. [PubMed] [Google Scholar]
- Klar A., Corcos A. P., Gross-Kieselstein E., Reifen R. M., Navon P., Branski D. Near normalization of metabolic abnormalities by prolonged CSII in a girl with congenital lipodystrophy. Diabetes Care. 1987 Mar-Apr;10(2):257–259. doi: 10.2337/diacare.10.2.257b. [DOI] [PubMed] [Google Scholar]
- Köbberling J., Dunnigan M. G. Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state. J Med Genet. 1986 Apr;23(2):120–127. doi: 10.1136/jmg.23.2.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Köbberling J., Willms B., Kattermann R., Creutzfeldt W. Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetes. Humangenetik. 1975 Sep 10;29(2):111–120. doi: 10.1007/BF00430347. [DOI] [PubMed] [Google Scholar]
- Reardon W., Temple I. K., Mackinnon H., Leonard J. V., Baraitser M. Partial lipodystrophy syndromes--a further male case. Clin Genet. 1990 Nov;38(5):391–395. doi: 10.1111/j.1399-0004.1990.tb03602.x. [DOI] [PubMed] [Google Scholar]
- SENIOR B., GELLIS S. S. THE SYNDROMES OF TOTAL LIPODYSTROPHY AND OF PARTIAL LIPODYSTROPHY. Pediatrics. 1964 Apr;33:593–612. [PubMed] [Google Scholar]
- Simpson H. C., Sturley R., Stirling C. A., Reckless J. P. Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients. Diabet Med. 1990 Feb;7(2):143–147. doi: 10.1111/j.1464-5491.1990.tb01349.x. [DOI] [PubMed] [Google Scholar]